Neurogastrx, Inc.

Neurogastrx, Inc.

http://www.neurogastrx.com/
Tags:BusinessDevelopmentDrugFinanceFinTechManagementPharmacyResearchSpecialty
We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. Our management team and board of directors are comprised of professionals with extensive backgrounds in drug research and development, commercialization, finance and business development for leading global pharmaceutical companies and growth-stage biopharmaceutical companies. Our scientific advisory board consists of well-known gastroenterologists and clinical thought leaders. Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with chronic and debilitating GI disorders that are not adequately controlled.
Location: United States, Massachusetts, Woburn
Member count: 11-50
Total raised: $105M
Founded date: 2012

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
26.08.2021Series B$60M--
04.01.2018Series A$45M--

Mentions in press and media 13

DateTitleDescriptionCategoryAuthorSource
27.08.2021Daily fund...Picsart has raised $130M; Neur...-Kristin Ka...vator.tv/n...
26.08.2021Neurogastr...Neurogastrx, Inc., a privately...--marketscre...
26.08.2021Neurogastr...---orbimed.co...
26.08.2021Neurogastr...---vivocapita...
26.08.2021Neurogastr...Neurogastrx thinks its late-st...Biotech-fiercebiot...
26.08.2021Neurogastr...---vivocapita...
26.08.2021Neurogastr...---5amventure...
26.08.2021Af­ter pan...Two years af­ter snar­ing a $4...FinancingJason Mastendpts.com...
08.06.2021Neurogastr... WOBURN, Mass., June 8, 2021 ...--prnewswire...
05.01.2018Term Sheet...THE BILLIONAIRE CLUB Happy Fr...--fortune.co...
Show more